FDA Advisory Panel Recommends Approval Of Implantable Opioid Device

The New York Times (1/13, A11, Tavernise, Subscription Publication) reports that a Food and Drug Administration advisory panel voted 12 to 5 to recommend approval of “a new way of treating opioid addicts, using a slender rod implanted into the arm that delivers medicine for months at a time.” The device, “about the size of a small matchstick,” administers daily doses of buprenorphine for periods of six months.

USA Today (1/13, Szabo) reports that the device “has been shown to ease withdrawal symptoms, decrease cravings and cut the risk of relapse.”

Related Links:

— “Implant for Opioid Addicts Urged for Federal Approval,” Sabrina Tavernise, New York Times, January12 , 2016.

Posted in In The News.